Literature DB >> 10733035

Anthropometry in relation to prostate cancer risk in the Netherlands Cohort Study.

A G Schuurman1, R A Goldbohm, E Dorant, P A van den Brandt.   

Abstract

In the Netherlands Cohort Study, the authors investigated whether anthropometry is associated with prostate cancer risk. At baseline in 1986, 58,279 men aged 55-69 years completed a self-administered questionnaire on diet, anthropometry, and other risk factors for cancer. After 6.3 years of follow-up, 681 cases were available with complete data on height and weight at baseline, and for 523 cases, there were data for weight at age 20 years. In both age-adjusted and multivariate case-cohort analyses (adjusted for age, family history of prostate cancer, and socioeconomic status), height, body mass index (BMI; kg/m2), and lean body mass (kg) at baseline were not associated with prostate cancer risk. The rate ratios of prostate cancer for men with a BMI at age 20 of less than 19, 19-20.9, 21-22.9, 23-24.9, and 25 or greater were 1.00 (reference), 1.06, 1.09, 1.39, and 1.33, respectively (p for trend = 0.02). For gain in BMI from age 20 years to age of the cohort at baseline, an inverse trend in risk was found (p for trend = 0.01), which did not persist after additional adjustment for BMI at age 20 (p for trend = 0.07). In subgroup analyses, no clear associations between anthropometry and advanced prostate cancer were found. Our findings suggest that body composition in young adulthood may already exert an effect on later risk of prostate cancer.

Entities:  

Mesh:

Year:  2000        PMID: 10733035     DOI: 10.1093/oxfordjournals.aje.a010241

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  38 in total

Review 1.  Lifestyle and dietary factors in the prevention of lethal prostate cancer.

Authors:  Kathryn M Wilson; Edward L Giovannucci; Lorelei A Mucci
Journal:  Asian J Androl       Date:  2012-04-16       Impact factor: 3.285

2.  Obesity and mortality in men with locally advanced prostate cancer: analysis of RTOG 85-31.

Authors:  Jason A Efstathiou; Kyounghwa Bae; William U Shipley; Gerald E Hanks; Miljenko V Pilepich; Howard M Sandler; Matthew R Smith
Journal:  Cancer       Date:  2007-12-15       Impact factor: 6.860

3.  Body mass index affects the diagnosis and progression of prostate cancer in Hispanics.

Authors:  Rosa Negrón; Andrea Vásquez; Mariely Nieves; Lourdes Guerrios; Margarita Irizarry-Ramírez
Journal:  Ethn Dis       Date:  2010       Impact factor: 1.847

4.  Association of obesity and smoking with PSA and PSA velocity in men with prostate cancer.

Authors:  Amit M Algotar; Steven P Stratton; James Ranger-Moore; M Suzanne Stratton; C H Hsu; Frederick R Ahmann; Raymond B Nagle; Patricia A Thompson
Journal:  Am J Mens Health       Date:  2011-05

5.  Obesity and Prostate Cancer Risk According to Tumor TMPRSS2:ERG Gene Fusion Status.

Authors:  Lieke Egbers; Manuel Luedeke; Antje Rinckleb; Suzanne Kolb; Jonathan L Wright; Christiane Maier; Marian L Neuhouser; Janet L Stanford
Journal:  Am J Epidemiol       Date:  2015-04-07       Impact factor: 4.897

6.  Body mass index adjusted prostate-specific antigen and its application for prostate cancer screening.

Authors:  Yuanyuan Liang; Donna P Ankerst; Michael Sanchez; Robin J Leach; Ian M Thompson
Journal:  Urology       Date:  2010-08-24       Impact factor: 2.649

7.  Body size across the life course and prostate cancer in the Health Professionals Follow-up Study.

Authors:  Elisabeth Möller; Kathryn M Wilson; Julie L Batista; Lorelei A Mucci; Katarina Bälter; Edward Giovannucci
Journal:  Int J Cancer       Date:  2015-09-23       Impact factor: 7.396

8.  Body mass index and cancer incidence: the FINRISK study.

Authors:  Xin Song; Eero Pukkala; Tadeusz Dyba; Jaakko Tuomilehto; Vladislav Moltchanov; Satu Männistö; Pekka Jousilahti; Qing Qiao
Journal:  Eur J Epidemiol       Date:  2014-07-06       Impact factor: 8.082

9.  Body mass index and prostate cancer severity: do obese men harbor more aggressive disease on prostate biopsy?

Authors:  Karim Chamie; Stephanie Oberfoell; Lorna Kwan; Jessica Labo; John T Wei; Mark S Litwin
Journal:  Urology       Date:  2013-03-07       Impact factor: 2.649

10.  Height and prostate cancer risk: a large nested case-control study (ProtecT) and meta-analysis.

Authors:  Luisa Zuccolo; Ross Harris; David Gunnell; Steven Oliver; Jane Athene Lane; Michael Davis; Jenny Donovan; David Neal; Freddie Hamdy; Rebecca Beynon; Jelena Savovic; Richard Michael Martin
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-09       Impact factor: 4.254

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.